- Home
- IVDA vs INDP Comparison
IVDA vs INDP Comparison
Compare IVDA & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- INDP
- Stock Information
- Founded
- IVDA 2003
- INDP 2000
- Country
- IVDA United States
- INDP United States
- Employees
- IVDA N/A
- INDP N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- INDP Biotechnology: Pharmaceutical Preparations
- Sector
- IVDA Technology
- INDP Health Care
- Exchange
- IVDA Nasdaq
- INDP Nasdaq
- Market Cap
- IVDA 9.3M
- INDP 8.8M
- IPO Year
- IVDA N/A
- INDP N/A
- Fundamental
- Price
- IVDA $2.59
- INDP $0.50
- Analyst Decision
- IVDA
- INDP Strong Buy
- Analyst Count
- IVDA 0
- INDP 2
- Target Price
- IVDA N/A
- INDP $8.50
- AVG Volume (30 Days)
- IVDA 36.8K
- INDP 1.2M
- Earning Date
- IVDA 05-19-2025
- INDP 03-13-2025
- Dividend Yield
- IVDA N/A
- INDP N/A
- EPS Growth
- IVDA N/A
- INDP N/A
- EPS
- IVDA N/A
- INDP N/A
- Revenue
- IVDA $5,305,155.00
- INDP N/A
- Revenue This Year
- IVDA $23.76
- INDP N/A
- Revenue Next Year
- IVDA $229.89
- INDP N/A
- P/E Ratio
- IVDA N/A
- INDP N/A
- Revenue Growth
- IVDA N/A
- INDP N/A
- 52 Week Low
- IVDA $1.27
- INDP $0.47
- 52 Week High
- IVDA $8.05
- INDP $3.10
- Technical
- Relative Strength Index (RSI)
- IVDA 48.89
- INDP 24.26
- Support Level
- IVDA $2.06
- INDP $0.58
- Resistance Level
- IVDA $3.55
- INDP $0.78
- Average True Range (ATR)
- IVDA 0.33
- INDP 0.14
- MACD
- IVDA -0.00
- INDP -0.03
- Stochastic Oscillator
- IVDA 35.57
- INDP 1.89
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc is engaged in offering real-time IP video surveillance technologies. The company provides IoT sensors and devices for various applications such as energy management, smart homes, smart buildings, smart communities, and patients and eldercare. Its IvedaAI provides AI functions to IP cameras and network video recorders and video management systems. The group has a business presence in the U.S. and the Republic of China (Taiwan), from which key revenue is derived from the Republic of China (Taiwan).
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.